BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28573906)

  • 1. Loss of CD3 and TCRγδ expression in a relapsed hepatosplenic T-cell lymphoma.
    Hodkoff A; Bentley P; Xu X
    Leuk Lymphoma; 2018 Feb; 59(2):479-481. PubMed ID: 28573906
    [No Abstract]   [Full Text] [Related]  

  • 2. Gamma/delta T cell lymphoma.
    Taguchi A; Miyazaki M; Sakuragi S; Shinohara K; Kamei T; Inoue Y
    Intern Med; 2004 Feb; 43(2):120-5. PubMed ID: 15005254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtle skin infiltration in hepatosplenic γδ T cell lymphoma.
    Yeung CK; Leung AY; Trendell-Smith NJ; Kwong YL
    Histopathology; 2012 Jul; 61(1):131-2. PubMed ID: 22486414
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatosplenic gammadelta T-cell lymphoma: difficulty in diagnosis.
    Yamaguchi M
    Intern Med; 2004 Feb; 43(2):83-4. PubMed ID: 15005247
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome).
    Motta G; Vianello F; Menin C; De Nicolo A; Agata S; Altavilla G; Pietrogrande F; Girolami A
    Am J Hematol; 2002 Apr; 69(4):272-6. PubMed ID: 11921021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Education and imaging. Hepatobiliary and pancreatic: hepatosplenic gamma-delta T-cell lymphoma.
    Qi X; Han G; He C; Guo W; Fan D
    J Gastroenterol Hepatol; 2012 Jan; 27(1):184. PubMed ID: 22188031
    [No Abstract]   [Full Text] [Related]  

  • 7. The first case report of composite bone marrow involvement by simultaneously developed peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma.
    Kim HK; Park CJ; Jang S; Cho YU; Park SH; Choi J; Park CS; Huh J; Chung YH; Lee JH
    Ann Lab Med; 2015 Jan; 35(1):152-4. PubMed ID: 25553299
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatosplenic T-cell lymphoma with coexistent hepatitis B infection: a rare clinicopathologic entity.
    Siraj F; Dalal V; Khan AA; Jain D
    Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26481866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of CD20 expression in peripheral T-cell lymphomas: a multi-center retrospective study.
    Toya T; Nannya Y; Hangaishi A; Shiseki M; Shimoyama T; Sakamaki H; Motoji T; Usuki K; Nakamura F; Kurokawa M
    Leuk Lymphoma; 2016; 57(4):961-4. PubMed ID: 26366623
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral T-cell lymphoma with unusual clinical presentation of rhabdomyolysis.
    Liu Z; Medeiros LJ; Young KH
    Hematol Oncol; 2017 Mar; 35(1):125-129. PubMed ID: 25921311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advance in peripheral T-cell lymphoma, not otherwise specified].
    Duan R; Zhang JZ
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):427-9. PubMed ID: 21055168
    [No Abstract]   [Full Text] [Related]  

  • 12. Rare variety of T-cell lymphoma.
    Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
    J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders.
    Salhany KE; Feldman M; Peritt D; Nowell PC
    Blood; 1997 May; 89(9):3490-1. PubMed ID: 9129060
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.
    Suarez F; Wlodarska I; Rigal-Huguet F; Mempel M; Martin-Garcia N; Farcet JP; Delsol G; Gaulard P
    Am J Surg Pathol; 2000 Jul; 24(7):1027-32. PubMed ID: 10895827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatosplenic gamma/delta T-cell lymphoma with isochromosome 7q, translocation t(7;21), and tetrasomy 8 in a 9-year-old girl.
    Rossbach HC; Chamizo W; Dumont DP; Barbosa JL; Sutcliffe MJ
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):154-7. PubMed ID: 11990705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma.
    Ham JS; Kim SJ; Choi JY; Hyun SH; Choi SK; Kim HS; Lim SH; Lee JY; Jung SH; Ko YH; Kim WS
    Blood Cancer J; 2016 Feb; 6(2):e395. PubMed ID: 26871713
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of constitutively activated NF-κB/mTORC pathway proteins and response to CHOP with bortezomib in a patient with angioimmunoblastic peripheral T-cell lymphoma.
    Quesada AE; Rios A; Brown RE; Nguyen ND
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S87-9. PubMed ID: 25486962
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis and treatment of peripheral T-cell lymphoma].
    Suzumiya J; Moriyama I; Kawakami K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():519-24. PubMed ID: 23134009
    [No Abstract]   [Full Text] [Related]  

  • 19. Large solitary splenic diffuse large B cell lymphoma in a hepatitis C virus-infected patient.
    Kedmi M; Fridlander T; Ilan Y; Shibolet O
    Isr Med Assoc J; 2005 May; 7(5):346-7. PubMed ID: 15909475
    [No Abstract]   [Full Text] [Related]  

  • 20. T-cell gamma/delta hepatosplenic lymphoma - prolonged remission induced by aggressive first line treatment.
    Procházka V; Papajík T; Jarosová M; Pikalová Z; Indrák K; Tichý M; Kucerová L; Fakan F; Bílý M; Starostka D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):275-6. PubMed ID: 16601770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.